PHAXIAM Therapeutics Competitors and Similar CompaniesClear all
PHAXIAM Therapeutics's competitors and similar companies include Aeglea.
 PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. | |
Founding Date | Founding Date 2004 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lyon, FR HQ Cambridge, US Princeton, US | Locations Austin, US HQ |
Employees | Employees 49 | Employees 65117% increase |
Valuation ($) | Valuation ($) 52.8 m | Valuation ($) 48.6 m |
Financial | ||
Net income | Net income (€23.5m) (FY, 2023) | Net income ($155.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Aeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View company